Lachenmayer and colleagues reported the significant upregulated expression of HDAC2, HDAC4, and HDAC11 in a cohort of liver cancer patients, whereas HDAC3 and HDAC5 were found to be associated with copy number gains in human HCC [90]. Here, HDAC11 is linked to liver cancer.